Higosensesp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 90 days for 2021). 1 of 6 audited by a statutory auditor.
- 202527/07/2026
- 202426/06/2025
- 202323/08/2024
- 202204/07/2023
- 202113/10/2022
- 202012/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the company is represented by one member of the management board. In the case of a multi-member management board, the company is represented by two members of the management board acting jointly.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Cogito Fund i Scsp Sicav-raif | 11,129 | $150,310.64 | 19.504% |
Flamingos Cloud Limited | 17,697 | – | 0% |
Łukasz Krasnopolskiage 45 | 4,774 | $64,478.66 | 8.3666% |
Smart Runner Fundusz Inwestycyjny Zamknięty Aktywów Niepublicznych | 6,750 | $91,166.94 | 11.8297% |
| 10,142 | $136,980.01 | 17.7743% | |
Upnorth Group Oü | 3,550 | $47,947.06 | 6.2215% |
Others | 30,801 | $279,781.20 | 36.3039% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Higo Medsp. z o.o. | 13,506.21 USD | 50% |
Bank accounts
Registered as a VAT taxpayer on 2017-07-31.
17 1050 1025 1000 0090 8449 7438- 80 1050 1025 1000 0090 8429 0858
40 1160 2202 0000 0005 0413 6632
Debt
No entries in the National Debtors Register (KRZ).
Public aid
12 public aid cases recorded, with a total value of $4,422,022.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 27, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $44,705$44,705 | Górnośląski Akcelerator Przedsiębiorczości Rynkowej sp. z o.o. | |
| Nov 10, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $42,027$42,027 | Górnośląski Akcelerator Przedsiębiorczości Rynkowej sp. z o.o. | |
| Jan 28, 2021 | Aid for research and development projects: experimental development | $1.1M$1,113,535 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-06-23 | Development of a product for telemedical diagnostics for adults in primary healthcare | $1.6M$1,600,903 | Operational Programme Smart Growth | |
| 2019-01-01 | HIGO SENSE - a telemedicine system for remote paediatric diagnostics based on an innovative multi-sensor device and automatic interpretation algorithms | $2.4M$2,437,790 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fluence Technologysp. z o.o. | $2,486,673.06 | fluence.pl | ||
| Oncotransfersp. z o.o. | $704,767.72 | oncotransfer.pib-nio.pl | ||
| Smart FluidS.A. | $681,963.98 | smartfluid.pl | ||
| Lymelab Pharma sp. z o.o.sp. k. | $424,756.39 | lymelabpharma.com | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-03-07 | Switch to PKD 2025 (9 PKD 2007 codes → 6 PKD 2025 codes) | |
| 2022-04-13 | Share capital increase (1,581,300.00 PLN → 2,083,750.00 PLN) | |
| 2021-04-27 | Share capital increase (1,163,900.00 PLN → 1,581,300.00 PLN) | |
| 2020-05-29 | Name change (Horizen → Higosense) | |
| 2020-05-20 | Share capital increase (1,117,700.00 PLN → 1,163,900.00 PLN) |
FAQ
Last updated: 2026-10-07